晚期抗生素与液体复苏干预在重度小鼠脓毒症模型中允许延长病程并保持高生存率
该研究在17–18周龄C57BL/6小鼠通过盲肠浆液(CS)注射建立重度致死性腹腔感染模型。CS注射后1或6小时早期启动抗生素(亚胺培南,1.5 mg/只,腹腔注射,每日两次,共5天)可挽救大多数小鼠,但少有菌血症、细胞因子血症或器官损伤证据;延迟至12或24小时启动抗生素则大多数动物48小时内死亡。在这些晚期时间点联合液体复苏(生理盐水,皮下注射)与抗生素(每日两次)后,大多数小鼠存活(75%),并出现菌血症、细胞因子血症、器官功能障碍和持续体重下降(4周内<90%)。作者推荐在菌血症明显后晚期启动该重复联合治疗,认为该模型更接近临床重度脓毒症的下游病理特征且保持高生存率。
要点
- CS注射后1或6小时早期启动亚胺培南(1.5 mg/只,腹腔注射,每日两次,共5天)可挽救大多数小鼠,但少有菌血症、细胞因子血症或器官损伤证据。
- CS注射后12或24小时延迟启动抗生素则大多数动物48小时内死亡。
- 在12或24小时晚期时间点联合液体复苏(生理盐水,皮下注射)与抗生素(每日两次)后,大多数小鼠存活(75%),并出现菌血症、细胞因子血症、器官功能障碍和持续体重下降(4周内<90%)。
- 作者推荐在菌血症明显后晚期启动该重复联合治疗,认为该模型更接近临床重度脓毒症的下游病理特征且保持高生存率。
适用人群与场景
- 17–18周龄年轻成年C57BL/6小鼠,通过盲肠浆液(CS)注射建立重度致死性腹腔感染模型。
处置流程与药物剂量
- 早期干预:CS注射后1或6小时启动亚胺培南1.5 mg/只,腹腔注射,每日两次,共5天。
- 晚期干预:CS注射后12或24小时启动抗生素(每日两次)联合液体复苏(生理盐水,皮下注射)。
研究设计与关键结果
- 研究类型:动物实验(小鼠脓毒症模型)。
- 早期(1或6小时)启动亚胺培南1.5 mg/只腹腔注射每日两次共5天可挽救大多数小鼠,但少有菌血症、细胞因子血症或器官损伤证据。
- 延迟至12或24小时启动抗生素则大多数动物48小时内死亡。
- 在12或24小时晚期时间点联合液体复苏(生理盐水,皮下注射)与抗生素(每日两次)后,大多数小鼠存活(75%),并出现菌血症、细胞因子血症、器官功能障碍和持续体重下降(4周内<90%)。
证据类型、等级与局限
- 证据类型:动物实验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者推荐在菌血症明显后晚期启动重复联合抗生素与液体复苏治疗,认为该模型更接近临床重度脓毒症的下游病理特征且保持高生存率。
- 作者认为该模型可用于重度脓毒症和重症后疾病(postintensive care illness)研究。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Current animal models of sepsis often incorporate antibiotics to be consistent with clinical standards for treatment of patients in the intensive care unit. However, such experimental intervention is commonly initiated very early after infectious insult, which likely blunts the progression of systemic inflammation and downstream pathology. The objective of this study was to establish an animal model of sepsis with delayed therapeutic intervention, allowing a longer disease course and downstream pathology, but still resulting in a high survival rate. Severe lethal abdominal infection was initiated in young adult (17-18-week-old) C57BL/6 mice by cecal slurry (CS) injection. When initiated early (1- or 6-h post-CS injection), antibiotic treatment (imipenem, 1.5 mg/mouse i.p., twice/day for 5 days) rescued the majority of mice; however, few of these mice showed evidence of bacteremia, cytokinemia, or organ injury. When antibiotic treatment was delayed until late time-points (12- or 24-h post-CS injection) the majority of animals did not survive beyond 48 h. When fluid resuscitation (physiological saline, s.c.) was performed in combination with antibiotic treatment (twice daily) beginning at these late time-points, the majority of mice survived (75%) and showed bacteremia, cytokinemia, organ dysfunction, and prolonged body weight loss (<90% for 4 weeks). We recommend that this new repeated combination treatment with antibiotics and fluids resuscitation be initiated at a late time point after bacteremia becomes evident because this model more closely mimics the downstream pathological characteristics of severe clinical sepsis yet maintains a high survival rate. This model would be advantageous for studies on severe sepsis and postintensive care illness.
参考来源
- Steele AM, Starr ME, Saito H, et al. Late Therapeutic Intervention with Antibiotics and Fluid Resuscitation Allows for a Prolonged Disease Course with High Survival in a Severe Murine Model of Sepsis. Shock. 2017. PMID: 27879561. doi:10.1097/SHK.0000000000000799
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。